{"schema_version":"secwatch.filing_event.v1","accession":"0001653477-25-000062","form_type":"8-K","ticker":"NGVT","cik":"0001653477","company_name":"Ingevity Corp","filed_at":"2025-05-05T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.216009+00:00","generated_at":"2026-05-22T17:38:26.881507+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ingevity Q1: adjusted EBITDA $91.3M (+23%); sales $284M (-17%); FY guidance revised","bullets":["Net sales $284.0M, down 17% YoY, due to Performance Chemicals repositioning and exit of lower-margin markets.","Net income $20.5M, diluted EPS $0.56; adjusted earnings $36.4M, adjusted EPS $0.99.","Adjusted EBITDA $91.3M (+23% YoY); margin improved to 32.1%.","Revised FY2025 guidance: sales $1.25B-$1.40B, adjusted EBITDA $380M-$415M, citing tariff uncertainty and auto production declines.","Operating cash flow $25.4M; free cash flow $15.4M."],"urls":{"canonical":"https://secwatch.observer/filing/0001653477-25-000062","json":"https://secwatch.observer/filing/0001653477-25-000062.json","markdown":"https://secwatch.observer/filing/0001653477-25-000062.md","text":"https://secwatch.observer/filing/0001653477-25-000062.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653477/000165347725000062/0001653477-25-000062-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653477/000165347725000062/ngvt-20250505.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-22T17:38:26.881507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}